No Data
No Data
ALTPLUSINC: (Numerical data correction) Partial correction of numerical data (XBRL) in the “Summary Financial Results for the 2nd Quarter Ending September 2024 [Japanese GAAP] (Consolidated)”
ALTPLUSINC: Confirmation letter
ALTPLUSINC: Quarterly Report - 15th Quarter 2nd Quarter (2024/01/01 - 2024/03/31)
AltPlusInc. 1H Loss Y201.00M Vs Loss Y257.00M
AltPlusInc. (3672.TO) Japan 1st Half Ended March 31 GROUP 2024 2023 Revenue Y1.94 bln Y2.14 bln Operating Profit (Y230.00 mln) (Y3
ALTPLUSINC: Summary of Financial Results for the 2nd Quarter Ending September 2024 [Japanese GAAP] (Consolidated)
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
No Data